ID

13757

Descripción

Study of Sapacitabine in Acute Myeloid Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01211457

Link

https://clinicaltrials.gov/show/NCT01211457

Palabras clave

Versiones (1)
  1. 3/3/16 3/3/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

3 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC-ND 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Myeloid Leukemia NCT01211457

Inglés

Eligibility Acute Myeloid Leukemia NCT01211457

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed aml based on who classification
Descripción

de novo aml

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1515568
age 70 years or older for whom the treatment of choice is low-intensity therapy by investigator assessment or who has refused intensive induction therapy recommended by investigator
Descripción

age and chemotherapy regimen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0392920
ecog performance status 0-2
Descripción

ECOG

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate renal function
Descripción

renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232804
adequate liver function
Descripción

liver function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
able to swallow capsules
Descripción

capsules

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006935
ability to understand and willingness to sign the informed consent form
Descripción

informed consent form

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
aml is of the sub-type of acute promyelocytic leukemia or extramedullary myeloid tumor without bone marrow involvement
Descripción

APL or extramedullary myeloid tumor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023487
UMLS CUI [2,1]
C2939461
UMLS CUI [2,2]
C1517060
having received any systemic anti-cancer therapy for aml or received treatment with hypomethylating agents or cytotoxic chemotherapy for the preceding mds or mpd
Descripción

prior therapy for aml

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1514463
UMLS CUI [2,1]
C2613367
UMLS CUI [2,2]
C0013227
UMLS CUI [3]
C0392920
UMLS CUI [4]
C3463824
known central nervous system (cns) involvement by leukemia
Descripción

cns leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1332884
uncontrolled intercurrent illness including
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
known hypersensitivity to decitabine
Descripción

hypersensitivity to decitabine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0049065
UMLS CUI [1,2]
C0020517
known to be hiv-positive
Descripción

hiv

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019682
Volver a la parte superior de la página

Similar models

Eligibility Acute Myeloid Leukemia NCT01211457

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
de novo aml
Item
newly diagnosed aml based on who classification
boolean
C0023467 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
age and chemotherapy regimen
Item
age 70 years or older for whom the treatment of choice is low-intensity therapy by investigator assessment or who has refused intensive induction therapy recommended by investigator
boolean
C0001779 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
ECOG
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
renal function
Item
adequate renal function
boolean
C0232804 (UMLS CUI [1])
liver function
Item
adequate liver function
boolean
C0232741 (UMLS CUI [1])
capsules
Item
able to swallow capsules
boolean
C0006935 (UMLS CUI [1])
informed consent form
Item
ability to understand and willingness to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
APL or extramedullary myeloid tumor
Item
aml is of the sub-type of acute promyelocytic leukemia or extramedullary myeloid tumor without bone marrow involvement
boolean
C0023487 (UMLS CUI [1])
C2939461 (UMLS CUI [2,1])
C1517060 (UMLS CUI [2,2])
prior therapy for aml
Item
having received any systemic anti-cancer therapy for aml or received treatment with hypomethylating agents or cytotoxic chemotherapy for the preceding mds or mpd
boolean
C0023467 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C2613367 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3])
C3463824 (UMLS CUI [4])
cns leukemia
Item
known central nervous system (cns) involvement by leukemia
boolean
C1332884 (UMLS CUI [1])
comorbidity
Item
uncontrolled intercurrent illness including
boolean
C0009488 (UMLS CUI [1])
hypersensitivity to decitabine
Item
known hypersensitivity to decitabine
boolean
C0049065 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
hiv
Item
known to be hiv-positive
boolean
C0019682 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial